CJC-1295 (No DAC) + Ipamorelin – User Manual & Dosage Protocol Guide

CJC-1295 (No DAC) is a synthetic growth hormone-releasing hormone (GHRH) analog without Drug Affinity Complex, meaning it has a shorter half-life compared to CJC-1295 DAC. Ipamorelin is a growth hormone-releasing peptide (GHRP).

When combined, they are used to synergistically stimulate endogenous growth hormone (GH) secretion, supporting tissue repair, fat metabolism, and muscle growth.

Research Applications:

• Enhancing lean muscle growth and body composition research
• Supporting fat metabolism and recovery studies
• Promoting cellular regeneration and anti-aging research
• Investigating GH pulsatility and IGF-1 modulation

Disclaimer: This combination peptide is for research and experimental use only. It is not FDA-approved for therapeutic purposes. Consult a qualified healthcare professional before use.

Product FormLyophilized Powder – Freeze-dried CJC-1295 (No DAC) + Ipamorelin for reconstitution

Injection Solution – Subcutaneous (SC) solution after reconstitution

• CJC-1295 (No DAC): Stimulates GH release quickly due to short half-life (approximately 30 minutes)
• Ipamorelin: Stimulates GH release via GHRP receptors, minimizing cortisol or prolactin stimulation
• Combination: Produces pulsatile GH release for optimized anabolic and regenerative effects
• Supports IGF-1 production, enhancing tissue repair and fat metabolism

Effects are primarily observed in preclinical and experimental protocols.

Administration

Subcutaneous (SC) Injection – Typical Dose: 100–150 µg CJC-1295 (No DAC) + 100–150 µg Ipamorelin | Frequency: 1–3× per day | Notes: Short half-life requires multiple daily injections for optimal GH pulse

Intramuscular (IM) Injection – Typical Dose: 100–150 µg each peptide | Frequency: 1–2× per day | Notes: Less common than SC; systemic delivery

Cycle Protocol (Investigational)

Initial Phase (1 week) – Dose: Lower end of dose range | Notes: Assess tolerance and GH response

Therapeutic Phase (2–6 weeks) – Dose: Full dose range | Notes: Maximum GH stimulation and regenerative effect

Rest Period (1–2 weeks) – Dose: None | Notes: Allows system to reset before next cycle

Multiple daily injections are typical due to the short half-life of CJC-1295 No DAC.

Supplies Needed:

• Sterile bacteriostatic water
• Sterile syringe
• Alcohol swabs

Steps:

1. Clean vial top with alcohol swab.
2. Add desired volume of bacteriostatic water (e.g., 2 mg peptide + 1 mL water → 2 mg/mL solution).
3. Swirl gently to dissolve; do not shake.
4. Store refrigerated (2–8°C).
5. Use within 1–2 weeks; discard if cloudy or discolored (shorter stability due to No DAC).

Subcutaneous Injection (SC)

1. Select a clean injection site (abdomen, thigh, or upper arm).
2. Clean site with alcohol swab.
3. Insert needle at 45° angle.
4. Inject slowly; apply gentle pressure afterward.
5. Rotate injection sites to avoid irritation.

Intramuscular Injection (IM)

1. Select clean muscle site (deltoid, glute, thigh).
2. Clean site with alcohol swab.
3. Insert needle at 90° angle; inject slowly.
4. Apply gentle pressure afterward.

Tip: Best GH stimulation is often achieved pre-bedtime or pre-workout, mimicking natural GH pulses.

Storage Information

Lyophilized Powder – Storage: Cool, dry place | Shelf Life: Up to 6–12 months

Reconstituted Solution – Storage: Refrigerate 2–8°C | Shelf Life: 1–2 weeks (short half-life)

Discard solution if cloudy, discolored, or containing particulates.

• Not recommended for pregnant or breastfeeding women
• Avoid if allergic to peptides
• Mild side effects: injection site irritation, headache, temporary water retention
• Discontinue if severe adverse reactions occur
• Keep out of reach of children

Human clinical data are limited; effects are investigational.

Weekly Dosing ScheduleWeek 1 – Dose: 100 µg CJC-1295 (No DAC) + 100 µg Ipamorelin SC 1× per day | Notes: Initial tolerance phase

Week 2–4 – Dose: 100–150 µg each SC 1–2× per day | Notes: Therapeutic phase

Week 5–6 – Dose: 150 µg each SC 2–3× per day | Notes: Full effect cycle

Week 7+ – Dose: Rest 1–2 weeks | Notes: Reset before next cycle

• Diagrams of SC and IM injection sites (abdomen, thigh, arm, deltoid, glute)
• Step-by-step reconstitution guide
• Safety icons for handling, storage, and injections